Cover Image
Market Research Report
Product code 
1045895

Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis

Published: | Renub Research | 145 Pages | Delivery time: 1-2 business days

Price

Back to Top
Oncology Precision Medicine Market, Size, Global Forecast 2022-2027, Industry Trends, Impact of COVID-19, Opportunity Company Analysis
Published: January 1, 2022
Renub Research
Content info: 145 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Over the years, the burden of cancer continues to grow globally, creating substantial pressure on patients, their families, communities and healthcare systems. Hence, precision medicine has been derived as a global healthcare approach, systematically using patient data to inform personalized treatment decisions. Precision medicine, a blend of molecular biology techniques and system biology, is an emerging approach in the medication and prevention of cancer. Prominently, around the world, oncology precision medicine has emerged as potentially transformative, offering promising superior treatment outcomes for all cancer patients. According to Renub Research, Global Oncology Precision Medicine Market is expected to reach US$ 64.66 Billion by 2027.

Covid-19- disrupted Progress in Oncology Precision Medicine Market:

Globally, the Covid-19 pandemic has severely impacted healthcare. Majorly for people living with cancer, the pandemic posed a unique set of challenges. Despite extraordinary advancements in precision medicine in helping reduce cancer mortality over the past years. The pandemic yielded early detection, workup, treatment, and biomarker testing trials and interrupted initiatives intended at extending access to targeted remedies that can improve patient consequences. However, with the ongoing vaccination program, the industry is gaining pace.

Global Oncology Precision Medicine Market is expected to grow at a CAGR of 11.6% during 2021-2027

Precision medicine, a novel approach to the treatment and prevention of cancer, uses a patient's complete medical profile from genetic data, medical history, environmental factors, and even lifestyle. Further, precision medicine aims to create a customized and unique treatment and prevention protocol for every patient. Hence, precision medicine is resonated to be known as personalized medicine as well. Besides, the concept of precision medicine with recent advances and new technology allows the pace of research to accelerate, further breaking new ground in cancer diagnostics.

Major Indications Revolving in Oncology Precision Medicine Market:

In the last two decades, knowledge of cancer has improved vastly, revealing the huge amongst cancer types and between patients of the same cancer type. Further, it highlights the need for and the promise of tailoring cancer care to handle individual patient characteristics through precision medicine. Remarkably, in our report, we have studied significant indications revolving in the Oncology Precision Medicine market, such as Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Cervical Cancer, Kidney Cancer and Bladder Cancer.

Worldwide Oncology Precision Medicine Market Size was US$ 33.40 Billion in 2021

Notwithstanding, the vision for precision medicine in cancer is transformative. Hence, precision medicine aims to deliver superior outcomes for all cancer patients and ultimately reduce the suffering caused by cancer. Further, fuelled by significant indications, cancer treatment is increasingly shifting towards precision medicine, a healthcare approach that systematically utilizes patient data to inform personalized treatment decisions. By Product Type - Oncology Precision Medicine Market has been segmented into Diagnostics and Therapeutics. However, new therapeutic approaches are getting us closer to a future where cancer becomes a curable disease.

North America the most dominant Market Shareholder

In the long term, regional realms of North America, Europe, Asia Pacific, Latin America and the Middle East & Africa have evolved further to harness comprehensive precision medicine to drive additional improvements in patient outcomes. The presence of better healthcare infrastructure and massive expenditure on R&D makes North America the most dominant market shareholder. Remarkably, there have been significant advances in precision medicine in North America for specific types of cancer treatments, such as colorectal cancer and breast cancer.

Furthermore, the Asia- Pacific's market share in the oncology precision medicine market is expected to grow at a vital rate due to advancing awareness about the consequence of precision medicine for the treatment of various variants of cancer and rising income and expenditure on healthcare.

Key Companies in the Global Precision Medicine Industry:

The Oncology Precision Medicine Market is highly competitive. Further, excitement from pharmaceutical companies also puts a focus on technological breakthroughs over health policy. Hence, several national initiatives to deliver on the promise of precision medicine in oncology exist. Our report has covered companies like F. Hoffmann - La Roche Ltd, Novartis AG, Bristol-Myers Squibb, Eli Lily and Co. and AstraZeneca that hold substantial shares in the market. These companies increase their market presence by introducing new technologies at affordable prices with technological advancements and product innovations.

Renub Research latest report "Oncology Precision Medicine Market, Global Forecast By Product Type (Diagnostics and Therapeutics), Indication (Lung Cancer, Stomach Cancer, Colorectal Cancer, Breast Cancer, Prostate Cancer, Liver Cancer, Oesophagus Cancer, Cervical Cancer, Kidney Cancer and Bladder Cancer), End Users (Hospitals, Diagnostic Centers, Research & Academic Institutes and Others), Region (North America, Europe, Asia Pacific, Latin America and the Middle East & Africa), Companies (F. Hoffmann - La Roche Ltd, Novartis AG, Bristol-Myers Squibb, Eli Lily and Co. and AstraZeneca)" provides a detailed analysis of Oncology Precision Medicine Industry.

Product Type - Oncology Precision Medicine Market have been covered from 2 viewpoints:

  • 1. Diagnostics
  • 2. Therapeutics

Indication - Oncology Precision Medicine Market have been covered from 11 viewpoints:

  • 1. Lung Cancer
  • 2. Stomach Cancer
  • 3. Colorectal Cancer
  • 4. Breast Cancer
  • 5. Prostate Cancer
  • 6. Liver Cancer
  • 7. Esophagus Cancer
  • 8. Cervical Cancer
  • 9. Kidney Cancer
  • 10. Bladder Cancer
  • 11. Other Cancers

End Users - Oncology Precision Medicine Market have been covered from 4 viewpoints:

  • 1. Hospitals
  • 2. Diagnostic Centers
  • 3. Research & Academic Institutes
  • 4. Others

Region - Oncology Precision Medicine Market have been covered from 5 viewpoints:

  • 1. North America
  • 2. Europe
  • 3. Asia Pacific
  • 4. Latin America
  • 5. Middle East & Africa

Company Insights:

  • Overview
  • Recent Development & Strategies
  • Financial Insights

Companies Covered:

  • 1. F. Hoffmann - La Roche Ltd
  • 2. Novartis AG
  • 3. Bristol-Myers Squibb
  • 4. Eli lily and Co.
  • 5. Astrazeneca

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

  • 4.1 Growth Drivers
  • 4.2 Challenges

5. Oncology Precision Medicine Market

6. Market Share - Oncology Precision Medicine Market

  • 6.1 By Product Type
  • 6.2 By Indication
  • 6.3 By End Users
  • 6.4 By Region

7. Product Type - Oncology Precision Medicine Market

  • 7.1 Diagnostics
  • 7.2 Therapeutics

8. Indication - Oncology Precision Medicine Market

  • 8.1 Lung Cancer
  • 8.2 Stomach Cancer
  • 8.3 Colorectal Cancer
  • 8.4 Breast Cancer
  • 8.5 Prostate Cancer
  • 8.6 Liver Cancer
  • 8.7 Esophagus Cancer
  • 8.8 Cervical Cancer
  • 8.9 Kidney Cancer
  • 8.10 Bladder Cancer
  • 8.11 Other Cancers

9. End Users- Oncology Precision Medicine Market

  • 9.1 Hospitals
  • 9.2 Diagnostic Centers
  • 9.3 Research & Academic Institutes
  • 9.4 Others

10. By Region- Oncology Precision Medicine Market

  • 10.1 North America
  • 10.2 Europe
  • 10.3 Asia Pacific
  • 10.4 Latin America
  • 10.5 Middle East & Africa

11. Porters Five Forces

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12. Company Analysis

  • 12.1 F. Hoffmann - La Roche Ltd
    • 12.1.1 Overview
    • 12.1.2 Recent Development & Strategies
    • 12.1.3 Financial Insights
  • 12.2 Novartis AG
    • 12.2.1 Overview
    • 12.2.2 Recent Development & Strategies
    • 12.2.3 Financial Insights
  • 12.3 Bristol-Myers Squibb
    • 12.3.1 Overview
    • 12.3.2 Recent Development & Strategies
    • 12.3.3 Financial Insights
  • 12.4 Eli lily and Co.
    • 12.4.1 Overview
    • 12.4.2 Recent Development & Strategies
    • 12.4.3 Financial Insights
  • 12.5 Astrazeneca
    • 12.5.1 Overview
    • 12.5.2 Recent Development & Strategies
    • 12.5.3 Financial Insights

List of Figures

  • Figure-01: Global - Oncology Precision Medicine Market (Billion US$), 2017 - 2021
  • Figure-02: Global - Forecast for Oncology Precision Medicine Market (Billion US$), 2022 - 2027
  • Figure-03: Product Type - Diagnostics Market (Billion US$), 2017 - 2021
  • Figure-04: Product Type - Forecast for Diagnostics Market (Billion US$), 2022 - 2027
  • Figure-05: Product Type - Therapeutics Market (Billion US$), 2017 - 2021
  • Figure-06: Product Type - Forecast for Therapeutics Market (Billion US$), 2022 - 2027
  • Figure-07: Indication - Lung Cancer Market (Billion US$), 2017 - 2021
  • Figure-08: Indication - Forecast for Lung Cancer Market (Billion US$), 2022 - 2027
  • Figure-09: Indication - Stomach Cancer Market (Billion US$), 2017 - 2021
  • Figure-10: Indication - Forecast for Stomach Cancer Market (Billion US$), 2022 - 2027
  • Figure-11: Indication - Colorectal Cancer Market (Billion US$), 2017 - 2021
  • Figure-12: Indication - Forecast for Colorectal Cancer Market (Billion US$), 2022 - 2027
  • Figure-13: Indication - Breast Cancer Market (Billion US$), 2017 - 2021
  • Figure-14: Indication - Forecast for Breast Cancer Market (Billion US$), 2022 - 2027
  • Figure-15: Indication - Prostate Cancer Market (Billion US$), 2017 - 2021
  • Figure-16: Indication - Forecast for Prostate Cancer Market (Billion US$), 2022 - 2027
  • Figure-17: Indication - Liver Cancer Market (Million US$), 2017 - 2021
  • Figure-18: Indication - Forecast for Liver Cancer Market (Million US$), 2022 - 2027
  • Figure-19: Indication - Esophagus Cancer Market (Million US$), 2017 - 2021
  • Figure-20: Indication - Forecast for Esophagus Cancer Market (Million US$), 2022 - 2027
  • Figure-21: Indication - Cervical Cancer Market (Billion US$), 2017 - 2021
  • Figure-22: Indication - Forecast for Cervical Cancer Market (Billion US$), 2022 - 2027
  • Figure-23: Indication - Kidney Cancer Market (Million US$), 2017 - 2021
  • Figure-24: Indication - Forecast for Kidney Cancer Market (Million US$), 2022 - 2027
  • Figure-25: Indication - Bladder Cancer Market (Billion US$), 2017 - 2021
  • Figure-26: Indication - Forecast for Bladder Cancer Market (Billion US$), 2022 - 2027
  • Figure-27: Indication - Other Cancers Market (Billion US$), 2017 - 2021
  • Figure-28: Indication - Forecast for Other Cancers Market (Billion US$), 2022 - 2027
  • Figure-29: End Users - Hospitals Market (Billion US$), 2017 - 2021
  • Figure-30: End Users - Forecast for Hospitals Market (Billion US$), 2022 - 2027
  • Figure-31: End Users - Diagnostic Centers Market (Billion US$), 2017 - 2021
  • Figure-32: End Users - Forecast for Diagnostic Centers Market (Billion US$), 2022 - 2027
  • Figure-33: End Users - Research & Academic Institutes Market (Billion US$), 2017 - 2021
  • Figure-34: End Users - Forecast for Research & Academic Institutes Market (Billion US$), 2022 - 2027
  • Figure-35: End Users - Others Market (Billion US$), 2017 - 2021
  • Figure-36: End Users - Forecast for Others Market (Billion US$), 2022 - 2027
  • Figure-37: North America - Oncology Precision Medicine Market (Billion US$), 2017 - 2021
  • Figure-38: North America - Forecast for Oncology Precision Medicine Market (Billion US$), 2022 - 2027
  • Figure-39: Europe - Oncology Precision Medicine Market (Billion US$), 2017 - 2021
  • Figure-40: Europe - Forecast for Oncology Precision Medicine Market (Billion US$), 2022 - 2027
  • Figure-41: Asia Pacific - Oncology Precision Medicine Market (Billion US$), 2017 - 2021
  • Figure-42: Asia Pacific - Forecast for Oncology Precision Medicine Market (Billion US$), 2022 - 2027
  • Figure-43: Latin America - Oncology Precision Medicine Market (Billion US$), 2017 - 2021
  • Figure-44: Latin America - Forecast for Oncology Precision Medicine Market (Billion US$), 2022 - 2027
  • Figure-45: Middle East & Africa - Oncology Precision Medicine Market (Million US$), 2017 - 2021
  • Figure-46: Middle East & Africa - Forecast for Oncology Precision Medicine Market (Million US$), 2022 - 2027
  • Figure-47: F. Hoffmann - La Roche Ltd - Global Revenue (Billion US$), 2017 - 2021
  • Figure-48: F. Hoffmann - La Roche Ltd - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-49: Novartis AG - Global Revenue (Billion US$), 2017 - 2021
  • Figure-50: Novartis AG - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-51: Bristol-Myers Squibb - Global Revenue (Billion US$), 2017 - 2021
  • Figure-52: Bristol-Myers Squibb - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-53: Eli lily and Co. - Global Revenue (Billion US$), 2017 - 2021
  • Figure-54: Eli lily and Co. - Forecast for Global Revenue (Billion US$), 2022 - 2027
  • Figure-55: Astrazeneca - Global Revenue (Billion US$), 2017 - 2021
  • Figure-56: Astrazeneca - Forecast for Global Revenue (Billion US$), 2022 - 2027

List of Tables

  • Table-01: Global - Oncology Precision Medicine Market Share by Product Type (Percent), 2017 - 2021
  • Table-02: Global - Forecast for Oncology Precision Medicine Market Share by Product Type (Percent), 2022 - 2027
  • Table-03: Global - Oncology Precision Medicine Market Share by Indication (Percent), 2017 - 2021
  • Table-04: Global - Forecast for Oncology Precision Medicine Market Share by Indication (Percent), 2022 - 2027
  • Table-05: Global - Oncology Precision Medicine Market Share by End User (Percent), 2017 - 2021
  • Table-06: Global - Forecast for Oncology Precision Medicine Market Share by End User (Percent), 2022 - 2027
  • Table-07: Global - Oncology Precision Medicine Market Share by Region (Percent), 2017 - 2021
  • Table-08: Global - Forecast for Oncology Precision Medicine Market Share by Region (Percent), 2022 - 2027